IOBT
IO Biotech Inc
NASDAQ: IOBT · HEALTHCARE · BIOTECHNOLOGY
$0.05
+0.00% today
Updated 2026-04-07
Market cap
$2.32M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.34
Dividend yield
—
52W range
$0 – $3
Volume
14.5M
WallStSmart proprietary scores
21
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C4.0
Quality
C3.0
Profitability
D5.0
Valuation
C+1/9
Piotroski F-Score
Weak
-9.9
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$2.18
+4441.67%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy1 Buy2 Hold1 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
Insufficient data
Risks
- Piotroski 1/9 — weak financial health
- Altman Z -9.85 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-18.48M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-67.88M | $-71.46M | $-86.08M | $-95.49M | $-8.38M |
| EPS | — | — | — | — | $-1.34 |
| Free cash flow | $-40.80M | $-60.42M | $-72.06M | $-82.39M | $-18.48M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
IO Biotech Inc trades at $0.05. Our Smart Value Score of 21/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of -9.85, it sits in the distress.
Frequently asked questions
What is IO Biotech Inc's stock price?
IO Biotech Inc (IOBT) trades at $0.05.
Is IO Biotech Inc overvalued?
IO Biotech Inc carries a Smart Value Score of 21/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of IO Biotech Inc (IOBT)?
The 12-month analyst consensus target is $2.18, about 4441.7% above the current $0.05. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
Altman Z-Score?
IO Biotech Inc's Altman Z-Score is -9.85, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-240.50%
Beta0.89
50D MA$0.28
200D MA$0.96
Shares out0.07B
Float0.04B
Short ratio—
Avg volume14.5M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—